Chenomx, Inc. Partners with Assay Depot to Offer Routine Metabolite Analysis Services for Drug Discovery

Share Article

Chenomx, Inc. (http://www.chenomx.com) is pleased to announce a partnership with Assay Depot (http://www.assaydepot.com) to offer routine metabolite analysis services for drug discovery. Chenomx offers a cost effective global profile of endogenous metabolites in biofluids and cell extracts. These profiles show the response of an organism's metabolism to potential drug targets and help researchers understand the systematic effects of their treatment.

Chenomx, Inc. is pleased to announce a partnership with Assay Depot (http://www.assaydepot.com) to offer routine metabolite analysis services for drug discovery. Chenomx offers a cost effective global profile of endogenous metabolites in biofluids and cell extracts. These profiles show the response of an organism's metabolism to potential drug targets and help researchers understand the systematic effects of their treatment.

Chenomx has offered outsourcing services since January 2006. With this partnership with Assay Depot, Chenomx makes metabolomics data more accessible and routine for a wide variety of academic and industry customers. Chenomx services offers analysis using its industry-leading Nuclear Magnetic Resonance (NMR)- based metabolomics software, providing a high-throughput, highly reproducible platform for metabolite identification and quantification.

David Chang, Contract Services Manager for Chenomx, comments "Chenomx provides its customers with an easy and cost effective method for looking at metabolism. We are offering our unique and patented approach to metabolomics directly to researchers, saving them the time and money involved with purchasing and maintaining complex analytical platforms. This will make additional metabolomic information available, allowing drug researchers better understand their genomics and proteomics data, and enabling them to make key decisions earlier in the drug discovery pipeline. Making our services available through Assay Depot will make the power of metabolomics accessible to an even broader range of researchers."

Assay Depot is an outsourcing marketplace for pharmaceutical research services. Assay Depot's mission is to make drug research outsourcing more accessible and useful to the research scientist and, in so doing, dramatically improve the way new medicines are discovered. "We are extremely pleased that Chenomx has chosen to offer their proprietary metabolomics analysis services on the Assay Depot marketplace," commented Kevin D. Lustig, PhD, CEO and President, Assay Depot. "Drug researchers using the marketplace can now access Chenomx' state-of-the-art NMR spectroscopic technologies and rapidly screen for the efficacy and safety of their drug candidates."

For further information on Chenomx Services, please visit http://www.chenomx.com/services.

About Chenomx, Inc.
Chenomx, Inc. specializes in the development of complex mixture analysis software for broad application in life science technologies. With world-class expertise in NMR spectroscopy, pharmaceutical sciences, and computer software, Chenomx offers a broad range of software products and services to support the metabolomics communities' research efforts. Chenomx's flagship product, Chenomx NMR Suite, provides a rich set of tools for identifying and quantifying metabolites in complex NMR Spectra. Chenomx also offers access to its technology platform through its Contract Services division. More information on Chenomx and its solutions is available at http://www.chenomx.com.

About Assay Depot
Assay Depot is an online marketplace for pharmaceutical research services. By acting as a single point of contact between researchers and service providers, the marketplace dramatically improves the efficiency of outsourcing. At Assay Depot, we make outsourcing easy.

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jack Newton
Visit website